Doug VanOort | Chairman, CEO |
Kathryn McKenzie | CFO |
Rob Shovlin | President, Clinical Division |
Bill Bonello | President, Informatics Division |
Doug Brown | Chief Strategy, CDO |
Charlie Eidson | Manager, IR |
Larry Weiss | CMO, Director of R&D |
George Cardoza | President, Pharma Services Division |
Lynn Tetrault | LID of Board of Directors |
David Westenberg | Guggenheim Securities |
Alex Nowak | Craig-Hallum Capital Group |
Mark Massaro | BTIG Research |
Tejas Savant | Morgan Stanley |
Brian Weinstein | William Blair |
Ivy Ma | Bank of America |
Good morning, ladies and gentlemen. And welcome to the NeoGenomics Quarter Four and Full Year 2020 Earnings Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host Doug VanOort, Chairman and CEO of NeoGenomics. Sir, the floor is yours.